PharmacyCodes



3-Methoxyamphetamine en es it fr

3-Methoxyamphetamine Brand names, 3-Methoxyamphetamine Analogs

3-Methoxyamphetamine Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

3-Methoxyamphetamine Chemical_Formula

C9H13N

3-Methoxyamphetamine RX_link

http://www.rxlist.com/cgi/generic3/adderallxr.htm

3-Methoxyamphetamine fda sheet

3-Methoxyamphetamine msds (material safety sheet)

3-Methoxyamphetamine Synthesis Reference

U. S. Pat. 1,879,003, (1932)

3-Methoxyamphetamine Molecular Weight

135.206 g/mol

3-Methoxyamphetamine Melting Point

Volatizes slowly at room temperature

3-Methoxyamphetamine H2O Solubility

Slightly

3-Methoxyamphetamine State

Solid

3-Methoxyamphetamine LogP

1.799

3-Methoxyamphetamine Dosage Forms

Capsules

3-Methoxyamphetamine Indication

For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

3-Methoxyamphetamine Pharmacology

Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

3-Methoxyamphetamine Absorption

It forms easily absorbed molecules that are highly lipid soluble

3-Methoxyamphetamine side effects and Toxicity

LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

3-Methoxyamphetamine Patient Information

Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

3-Methoxyamphetamine Organisms Affected

Humans and other mammals